COSMOS Pharmaceutical Corporation
3349.T · JPX
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | ¥698,573,613 | ¥699,997,824 | ¥558,209,417 | ¥585,315,426 |
| - Cash | ¥49,538,000 | ¥57,038,000 | ¥22,765,000 | ¥39,129,000 |
| + Debt | ¥41,546,000 | ¥49,957,000 | ¥28,529,000 | ¥25,675,000 |
| Enterprise Value | ¥690,581,613 | ¥692,916,824 | ¥563,973,417 | ¥571,861,426 |
| Revenue | ¥272,394,000 | ¥259,122,000 | ¥246,332,000 | ¥244,095,000 |
| % Growth | 5.1% | 5.2% | 0.9% | – |
| Gross Profit | ¥57,175,000 | ¥54,073,000 | ¥53,134,000 | ¥51,511,000 |
| % Margin | 21% | 20.9% | 21.6% | 21.1% |
| EBITDA | ¥17,947,000 | ¥15,306,000 | ¥17,421,000 | ¥14,169,000 |
| % Margin | 6.6% | 5.9% | 7.1% | 5.8% |
| Net Income | ¥8,171,000 | ¥8,635,000 | ¥7,915,000 | ¥6,285,000 |
| % Margin | 3% | 3.3% | 3.2% | 2.6% |
| EPS Diluted | 103.09 | 108.95 | 99.86 | 79.3 |
| % Growth | -5.4% | 9.1% | 25.9% | – |
| Operating Cash Flow | – | ¥0 | ¥0 | ¥0 |
| Capital Expenditures | – | ¥0 | ¥0 | ¥0 |
| Free Cash Flow | – | ¥0 | ¥0 | ¥0 |